Key Metrics
CiteScore 

5.1
H-Index 

87
Impact Factor 

< 5
SJR 

Q2Oncology

SNIP 

0.98
Recommended pre-submission checks
Powered by 

Topics Covered on Medical Oncology
Medical Oncology Journal Specifications
| Overview | |
| Publisher | HUMANA PRESS INC |
| Language | English |
| Frequency | Continuous publication |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 1984 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Medical Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Medical Oncology
Iron oxide nanoparticles co-conjugated with hyaluronic acid and limonene trigger oxidative stress and cell cycle arrest in triple-negative breast cancer.
- 7 Aug 2026
- Medical oncology (Northwood, London, England)
Current status and challenges of immune checkpoint inhibitors in liver cancer: from monotherapy to combination strategies.
- 7 Aug 2026
- Medical oncology (Northwood, London, England)
Genomic, transcriptomic, and molecular predictors of response to neoadjuvant therapy in locally advanced rectal cancer: a narrative review.
- 7 Aug 2026
- Medical oncology (Northwood, London, England)
Survivin mRNA lipid nanoparticles and CTLA-4 inhibitor co-delivery activates anti-tumor cytotoxic T-lymphocytes for oral cancer immunotherapy.
- 7 Aug 2026
- Medical oncology (Northwood, London, England)
Mesenchymal stromal cells regulate M2 macrophage polarization that promotes proliferation, migration, and invasion of renal cell carcinoma cells.
- 7 Aug 2026
- Medical oncology (Northwood, London, England)
Development and validation of a nomogram for predicting venous thromboembolism risk in colorectal cancer patients undergoing postoperative chemotherapy.
- 7 Aug 2026
- Medical oncology (Northwood, London, England)
Iron oxide nanoparticles co-conjugated with hyaluronic acid and limonene trigger oxidative stress and cell cycle arrest in triple-negative breast cancer.
- 7 Aug 2026
- Medical oncology (Northwood, London, England)
Current status and challenges of immune checkpoint inhibitors in liver cancer: from monotherapy to combination strategies.
- 7 Aug 2026
- Medical oncology (Northwood, London, England)
Genomic, transcriptomic, and molecular predictors of response to neoadjuvant therapy in locally advanced rectal cancer: a narrative review.
- 7 Aug 2026
- Medical oncology (Northwood, London, England)
Survivin mRNA lipid nanoparticles and CTLA-4 inhibitor co-delivery activates anti-tumor cytotoxic T-lymphocytes for oral cancer immunotherapy.
- 7 Aug 2026
- Medical oncology (Northwood, London, England)
Mesenchymal stromal cells regulate M2 macrophage polarization that promotes proliferation, migration, and invasion of renal cell carcinoma cells.
- 7 Aug 2026
- Medical oncology (Northwood, London, England)
Development and validation of a nomogram for predicting venous thromboembolism risk in colorectal cancer patients undergoing postoperative chemotherapy.
- 7 Aug 2026
- Medical oncology (Northwood, London, England)